These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 644715)

  • 1. [Suppression of leukocyte migration in bladder cancer with tumor antigens before and after surgery].
    Borisenko ID; Novikov DK; Shein IA
    Urol Nefrol (Mosk); 1978; (2):26-9. PubMed ID: 644715
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukocyte migration inhibition in vitro in bladder carcinoma.
    Lavergne JA; Lamm DL; Radwin HM; Harrington JT
    Cancer Res; 1979 Jun; 39(6 Pt 1):1985-8. PubMed ID: 445398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro migration inhibition of leukocytes from cancer patients by extracts of autologous and homologous tumors].
    Novikov DK; Adamenko GP
    Dokl Akad Nauk SSSR; 1974; 217(3):715-8. PubMed ID: 4848926
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of 3-hydroxyanthranilic acid-antigen on the migration of peripheral blood leukocytes in patients with bladder tumors].
    Korosteleva TA; Kliucharev BV; Skadova VM; Vorob'ev AV; Chebotkevich VN
    Vopr Onkol; 1987; 33(5):59-62. PubMed ID: 3296440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transitional cell carcinoma: circulating tumor antigen correlated with presence/absence of tumor (leukocyte migration assay).
    Bowen JG
    Natl Cancer Inst Monogr; 1978 Dec; (49):245-7. PubMed ID: 748778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin tests with soluble tumor membrane antigens in patients with transitional cell cancers.
    Hollinshead AC
    Natl Cancer Inst Monogr; 1978 Dec; (49):255-6. PubMed ID: 748779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3-HAA-antigen and immunoreactivity indices in patients with bladder tumors].
    Korosteleva TA; Rabkova LM; Belokhvostova AT; Movsesian KS; Skadova VM
    Vopr Onkol; 1986; 32(9):48-53. PubMed ID: 3765523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some uses and limitations of immunologic testing in human patients.
    Lavergne JA
    Bol Asoc Med P R; 1981 Apr; 73(4):141-5. PubMed ID: 6946780
    [No Abstract]   [Full Text] [Related]  

  • 9. Leukocyte migration inhibition response to various antigen preparations of autologous and homologous breast cancer in patients with primary breast cancer.
    Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH
    J Natl Cancer Inst; 1979 Nov; 63(5):1161-9. PubMed ID: 91696
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukocyte migration inhibition assay in patients with bladder cancer.
    Schellhammer PF; Wright GL; Rosato FE; Faulconer RJ
    J Urol; 1979 Dec; 122(6):746-9. PubMed ID: 513216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bladder tumors. Indications and results of systematic biopsies of optically normal mucosa (with a study of surface antigens)].
    Boccon-Gibod L; Boccon-Gibod L; Deslignères S; Janin-Mercier A
    Arch Anat Cytol Pathol; 1986; 34(4):224-9. PubMed ID: 3566364
    [No Abstract]   [Full Text] [Related]  

  • 12. [Behavior of the ABO(H) blood group antigens of the urothelial surface in bladder tumors].
    Proca E; Lucan M; Pîslăraşu M
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1987; 36(6):401-12. PubMed ID: 2964680
    [No Abstract]   [Full Text] [Related]  

  • 13. Decreased ability of blood leukocytes from patients with tumors of the urinary bladder to act as stimulator cells in mixed leukocyte culture.
    Herr HW; Bean MA; Whitmore WF
    Cancer Res; 1976 Aug; 36(8):2754-60. PubMed ID: 132272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of leukocyte migration by soluble tumor extracts in human malignant melanoma.
    Lapińska M; Jassem J; Kondrat W; Jaśkiewicz J
    Neoplasma; 1980; 27(1):37-42. PubMed ID: 6154899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behaviour of invasive bladder carcinomas immunohistological preliminary study of basement membrane antigens.
    Daher N; Abourachid H; Burtin P
    Prog Clin Biol Res; 1984; 162B():225-30. PubMed ID: 6390446
    [No Abstract]   [Full Text] [Related]  

  • 17. [Leukocyte adhesion suppression reaction for determining the immunological reactivity of oncological patients].
    Frolova LM; Govallo VI
    Vopr Onkol; 1978; 24(5):10-4. PubMed ID: 351953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of leukocyte sensitization to tumor and embryonic tissue antigens in cancer of the large intestine].
    Novikov DK; Shmakov AP
    Vopr Onkol; 1981; 27(8):40-5. PubMed ID: 6269300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of isoantigen in the management of the urinary bladder tumor--a basic study of ABO isoantigen in step sections of the entire bladder].
    Ogawa T; Sugimoto M; Hamami G; Kamidono S
    Hinyokika Kiyo; 1989 Jan; 35(1):13-25. PubMed ID: 2729014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Random biopsies in bladder tumors: in most cases, you shall not!
    Zlotta AR
    Eur Urol; 2006 Aug; 50(2):186-93. PubMed ID: 16814925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.